Aimei Health Technology (AFJK) Competitors

$40.06 0.00 (0.00%)

Closing price 05/22/2026 03:54 PM Eastern

Extended Trading

$40.70 +0.64 (+1.60%)

As of 05/22/2026 07:45 PM Eastern

AFJK vs. ANGX, CAEP, UROY, CHCT, and XRN

Should you buy Aimei Health Technology stock or one of its competitors? MarketBeat compares Aimei Health Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aimei Health Technology include Angel Studios (ANGX), Cantor Equity Partners III (CAEP), Uranium Royalty (UROY), Community Healthcare Trust (CHCT), and Global Medical REIT (XRN). These companies are all part of the "trading" industry.

How does Aimei Health Technology compare to Angel Studios?

Angel Studios (NYSE:ANGX) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

Aimei Health Technology's return on equity of -33.32% beat Angel Studios' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Angel Studios	N/A	-1,729.27%	-76.32%
Aimei Health Technology	N/A	-33.32%	2.91%

Aimei Health Technology has lower revenue, but higher earnings than Angel Studios. Angel Studios is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Angel Studios	$321.56M	1.64	-$170.48M	-$0.75	N/A
Aimei Health Technology	N/A	N/A	$1.06M	$0.18	222.56

38.6% of Angel Studios shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 30.1% of Angel Studios shares are held by insiders. Comparatively, 2.5% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Angel Studios has a beta of 0.04, indicating that its stock price is 96% less volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market.

In the previous week, Angel Studios and Angel Studios both had 2 articles in the media. Aimei Health Technology's average media sentiment score of 0.09 beat Angel Studios' score of 0.00 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Angel Studios	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aimei Health Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Angel Studios presently has a consensus price target of $8.25, suggesting a potential upside of 192.04%. Given Angel Studios' stronger consensus rating and higher possible upside, analysts plainly believe Angel Studios is more favorable than Aimei Health Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Angel Studios	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Aimei Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Aimei Health Technology beats Angel Studios on 8 of the 14 factors compared between the two stocks.

How does Aimei Health Technology compare to Cantor Equity Partners III?

Cantor Equity Partners III (NASDAQ:CAEP) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantor Equity Partners III	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aimei Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Aimei Health Technology's return on equity of -33.32% beat Cantor Equity Partners III's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cantor Equity Partners III	N/A	-68.99%	1.35%
Aimei Health Technology	N/A	-33.32%	2.91%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantor Equity Partners III	N/A	N/A	$3.61M	N/A	N/A
Aimei Health Technology	N/A	N/A	$1.06M	$0.18	222.56

In the previous week, Aimei Health Technology had 2 more articles in the media than Cantor Equity Partners III. MarketBeat recorded 2 mentions for Aimei Health Technology and 0 mentions for Cantor Equity Partners III. Aimei Health Technology's average media sentiment score of 0.09 beat Cantor Equity Partners III's score of 0.00 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Cantor Equity Partners III	Neutral
Aimei Health Technology	Neutral

45.6% of Aimei Health Technology shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Aimei Health Technology beats Cantor Equity Partners III on 6 of the 7 factors compared between the two stocks.

How does Aimei Health Technology compare to Uranium Royalty?

Uranium Royalty (NASDAQ:UROY) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

24.2% of Uranium Royalty shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Aimei Health Technology has lower revenue, but higher earnings than Uranium Royalty. Uranium Royalty is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uranium Royalty	$11.19M	44.11	-$4.06M	$0.02	168.50
Aimei Health Technology	N/A	N/A	$1.06M	$0.18	222.56

Uranium Royalty has a net margin of 7.70% compared to Aimei Health Technology's net margin of 0.00%. Uranium Royalty's return on equity of 0.01% beat Aimei Health Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Uranium Royalty	7.70%	0.01%	0.01%
Aimei Health Technology	N/A	-33.32%	2.91%

Uranium Royalty has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market.

In the previous week, Uranium Royalty had 2 more articles in the media than Aimei Health Technology. MarketBeat recorded 4 mentions for Uranium Royalty and 2 mentions for Aimei Health Technology. Uranium Royalty's average media sentiment score of 0.33 beat Aimei Health Technology's score of 0.09 indicating that Uranium Royalty is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Uranium Royalty	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aimei Health Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uranium Royalty	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Aimei Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Uranium Royalty beats Aimei Health Technology on 9 of the 15 factors compared between the two stocks.

How does Aimei Health Technology compare to Community Healthcare Trust?

Community Healthcare Trust (NYSE:CHCT) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap trading companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Community Healthcare Trust has higher revenue and earnings than Aimei Health Technology. Community Healthcare Trust is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Community Healthcare Trust	$121.19M	4.10	$5.10M	$0.11	158.04
Aimei Health Technology	N/A	N/A	$1.06M	$0.18	222.56

Community Healthcare Trust has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market.

Community Healthcare Trust has a net margin of 4.94% compared to Aimei Health Technology's net margin of 0.00%. Community Healthcare Trust's return on equity of 1.41% beat Aimei Health Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Community Healthcare Trust	4.94%	1.41%	0.61%
Aimei Health Technology	N/A	-33.32%	2.91%

In the previous week, Aimei Health Technology had 1 more articles in the media than Community Healthcare Trust. MarketBeat recorded 2 mentions for Aimei Health Technology and 1 mentions for Community Healthcare Trust. Community Healthcare Trust's average media sentiment score of 1.14 beat Aimei Health Technology's score of 0.09 indicating that Community Healthcare Trust is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Community Healthcare Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aimei Health Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.8% of Community Healthcare Trust shares are owned by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are owned by institutional investors. 5.3% of Community Healthcare Trust shares are owned by company insiders. Comparatively, 2.5% of Aimei Health Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Community Healthcare Trust currently has a consensus price target of $18.00, suggesting a potential upside of 3.54%. Given Community Healthcare Trust's stronger consensus rating and higher probable upside, analysts plainly believe Community Healthcare Trust is more favorable than Aimei Health Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Community Healthcare Trust	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Aimei Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Community Healthcare Trust beats Aimei Health Technology on 11 of the 15 factors compared between the two stocks.

How does Aimei Health Technology compare to Global Medical REIT?

Aimei Health Technology (NASDAQ:AFJK) and Global Medical REIT (NYSE:XRN) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Global Medical REIT has a consensus price target of $39.50, indicating a potential upside of 5.56%. Given Global Medical REIT's stronger consensus rating and higher probable upside, analysts clearly believe Global Medical REIT is more favorable than Aimei Health Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Global Medical REIT	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.43

45.6% of Aimei Health Technology shares are owned by institutional investors. Comparatively, 57.5% of Global Medical REIT shares are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by company insiders. Comparatively, 8.9% of Global Medical REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aimei Health Technology has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market. Comparatively, Global Medical REIT has a beta of 1.11, indicating that its share price is 11% more volatile than the broader market.

Aimei Health Technology has a net margin of 0.00% compared to Global Medical REIT's net margin of -6.06%. Global Medical REIT's return on equity of -2.19% beat Aimei Health Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-33.32%	2.91%
Global Medical REIT	-6.06%	-2.19%	-0.73%

Aimei Health Technology has higher earnings, but lower revenue than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aimei Health Technology	N/A	N/A	$1.06M	$0.18	222.56
Global Medical REIT	$148.21M	3.34	-$5.84M	-$1.11	N/A

In the previous week, Aimei Health Technology and Aimei Health Technology both had 2 articles in the media. Global Medical REIT's average media sentiment score of 0.23 beat Aimei Health Technology's score of 0.09 indicating that Global Medical REIT is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aimei Health Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Global Medical REIT	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Global Medical REIT beats Aimei Health Technology on 10 of the 15 factors compared between the two stocks.

Get Aimei Health Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFJK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AFJK vs. The Competition

Export

Metric	Aimei Health Technology	UNCLASSIFIED Industry	Financial Sector	NASDAQ Exchange
Market Cap	$126.84M	$162.95M	$5.90B	$12.34B
Dividend Yield	N/A	N/A	5.21%	5.28%
P/E Ratio	222.56	44.64	15.90	25.66
Price / Sales	N/A	125.86	1,011.40	86.31
Price / Cash	80.35	2,501.05	92.81	56.67
Price / Book	-20.97	5.06	6.60	7.14
Net Income	$1.06M	-$19.43M	$1.14B	$335.98M
7 Day Performance	-4.82%	1.31%	1.05%	4.15%
1 Month Performance	-15.13%	-2.53%	2.04%	2.54%
1 Year Performance	259.25%	4.36%	19.96%	35.06%

Aimei Health Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AFJK Aimei Health Technology	0.6726 of 5 stars	$40.06 flat	N/A	+259.3%	$126.84M	N/A	222.56	N/A	Gap Up
ANGX Angel Studios	3.2841 of 5 stars	$2.81 +7.1%	$8.25 +194.1%	N/A	$522.89M	$389.22M	N/A	N/A
CAEP Cantor Equity Partners III	N/A	$14.77 -1.5%	N/A	N/A	$518.13M	N/A	N/A	2	Gap Down
UROY Uranium Royalty	1.816 of 5 stars	$3.45 -1.0%	N/A	+44.6%	$504.62M	$11.19M	172.34	10	News Coverage Gap Up
CHCT Community Healthcare Trust	2.6749 of 5 stars	$17.46 -1.4%	$18.00 +3.1%	+9.5%	$498.98M	$122.64M	158.78	30	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AFJK) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aimei Health Technology (AFJK) Competitors

AFJK vs. ANGX, CAEP, UROY, CHCT, and XRN

How does Aimei Health Technology compare to Angel Studios?

Summary

How does Aimei Health Technology compare to Cantor Equity Partners III?

Summary

How does Aimei Health Technology compare to Uranium Royalty?

Summary

How does Aimei Health Technology compare to Community Healthcare Trust?

Summary

How does Aimei Health Technology compare to Global Medical REIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AFJK vs. The Competition

Aimei Health Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aimei Health Technology (AFJK) Competitors

AFJK vs. ANGX, CAEP, UROY, CHCT, and XRN

How does Aimei Health Technology compare to Angel Studios?

Is ANGX or AFJK more profitable?

Which has higher valuation & earnings, ANGX or AFJK?

Do institutionals and insiders hold more shares of ANGX or AFJK?

Which has more volatility & risk, ANGX or AFJK?

Does the media favor ANGX or AFJK?

Do analysts rate ANGX or AFJK?

Summary

How does Aimei Health Technology compare to Cantor Equity Partners III?

Do analysts prefer CAEP or AFJK?

Is CAEP or AFJK more profitable?

Which has stronger earnings & valuation, CAEP or AFJK?

Does the media prefer CAEP or AFJK?

Do insiders & institutionals hold more shares of CAEP or AFJK?

Summary

How does Aimei Health Technology compare to Uranium Royalty?

Do insiders and institutionals hold more shares of UROY or AFJK?

Which has higher earnings & valuation, UROY or AFJK?

Is UROY or AFJK more profitable?

Which has more volatility & risk, UROY or AFJK?

Does the media refer more to UROY or AFJK?

Do analysts recommend UROY or AFJK?

Summary

How does Aimei Health Technology compare to Community Healthcare Trust?

Which has better valuation and earnings, CHCT or AFJK?

Which has more volatility and risk, CHCT or AFJK?

Is CHCT or AFJK more profitable?

Does the media favor CHCT or AFJK?

Do insiders and institutionals hold more shares of CHCT or AFJK?

Do analysts rate CHCT or AFJK?

Summary

How does Aimei Health Technology compare to Global Medical REIT?

Do analysts prefer AFJK or XRN?

Do insiders & institutionals have more ownership in AFJK or XRN?

Which has more volatility and risk, AFJK or XRN?

Is AFJK or XRN more profitable?

Which has preferable valuation & earnings, AFJK or XRN?

Does the media refer more to AFJK or XRN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AFJK vs. The Competition

Aimei Health Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools